SCHEMBL7971678

SCHEMBL7971678

Cn1nc(-c2ccc(-c3cccc(N)c3)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
HPGD P15428 5/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
TP53 P04637 3/20 0.43
MAPT P10636 3/20 0.43
GFER P55789 3/20 0.43
PKM P14618 2/20 0.43
PRMT1 Q99873 1/20 0.42
HSD17B10 Q99714 2/20 0.41
CDK2 P24941 3/20 0.39
PRKCZ Q05513 2/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
POLB P06746 3/20 0.39
HTT P42858 2/20 0.39
GAA P10253 3/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7971397 0.91 ALDH1A1 (0.39) NPC1RAB9AHPGDALDH1A1KDM4E
SCHEMBL7962296 0.90 NPBWR1 (0.36) NPC1RAB9AHPGDALDH1A1KDM4E
SCHEMBL7972135 0.90 PDE10A (0.37) NPC1RAB9ASMN1; SMN2MAPTHSD17B10
SCHEMBL7971392 0.89 SCD (0.42) HPGDALDH1A1KDM4ETP53MAPT
SCHEMBL7971418 0.89 SCD (0.42) GAAHSD17B2SCD
SCHEMBL7971780 0.88 FGFR2 (0.40) CDK2PRKCZF7HSD17B2JAK2
SCHEMBL7971018 0.88 HSD17B10 (0.37) NPC1RAB9AHPGDALDH1A1KDM4E
SCHEMBL7974911 0.87 CHEK2 (0.43) PRKCZ
SCHEMBL7970587 0.87 TOP1 (0.34) HPGDALDH1A1SMN1; SMN2HSD17B10F10
SCHEMBL7973155 0.87 F9 (0.39) NPC1RAB9AHPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805939-B1 Heterocyclic compounds as factor IXA inhibitors. MERCK SHARP & DOHME (US) 2018-06-27 EP disclosed
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed